Immuno-Oncology 360° is a comprehensive program, which provides exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including: discovery/preclinical science; investor relations; translation science; emerging technologies; clinical development; trends in the field and more. This conference also provides the most up-to-date research, data and progress to help immune-oncology stakeholders be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy; Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof; receive the latest pre-clinical, translational and clinical data from academic and industry; identify and gain a greater understanding of what assets are available for potential combinations; create and prioritize strategies targeted toward specific tumor types​ and obtain coverage on a wide range of emerging technologies.

We hope to see you there!